Kirk Shona L, Cahir Marie, Reynolds Gavin P
Division of Psychiatry and Neuroscience, Queen's University Belfast, Belfast, UK.
J Psychopharmacol. 2006 Jul;20(4):577-9. doi: 10.1177/0269881106061199. Epub 2006 Jan 9.
Many atypical antipsychotic drugs, such as clozapine, can induce significant weight gain which can have serious implications for drug compliance and morbidity. Food intake and weight gain are regulated primarily by the hypothalamus; the arcuate nucleus (ARC) of the hypothalamus is the region initially mediating the effects of circulating hormones on food intake. Neuropeptide Y (NPY) is an important hypothalamic peptide involved in body weight regulation. Immunohistochemical staining of NPY in the ARC was carried out in male Sprague-Dawley rats treated with haloperidol (1.5 mg/kg, i.p.) or clozapine (25 mg/kg, i.p.) for 3 weeks. Clozapine, but not haloperidol, produced an increase in NPY immunoreactivity in the ARC, suggesting that effects on NPY may be involved in increases in body weight following clozapine treatment.
许多非典型抗精神病药物,如氯氮平,可导致显著体重增加,这可能对药物依从性和发病率产生严重影响。食物摄入和体重增加主要由下丘脑调节;下丘脑的弓状核(ARC)是最初介导循环激素对食物摄入影响的区域。神经肽Y(NPY)是一种参与体重调节的重要下丘脑肽。对用氟哌啶醇(1.5毫克/千克,腹腔注射)或氯氮平(25毫克/千克,腹腔注射)处理3周的雄性斯普拉格-道利大鼠的ARC中的NPY进行免疫组织化学染色。氯氮平而非氟哌啶醇使ARC中的NPY免疫反应性增加,这表明对NPY的影响可能与氯氮平治疗后体重增加有关。